Estrella Immunopharma, Inc. logo

Estrella Immunopharma, Inc. (ESLA) Q2 2024 Annual Earnings

ESLA·Reported September 27, 2024·Before market open

Diluted EPS came in at $-0.13.

Diluted EPS
$-0.13
SEC

SEC Filings

Earnings release8-K not filed yet
Annual report10-K · 0001213900-24-082374

Financial Snapshot

Trailing eight quarters through Q2 2024

View all metrics

Revenue

View metric

Net Income

View metric

Operating Cash Flow

View metric

EPS (Diluted)

View metric

Q2 2024 Earnings FAQ

Common questions about Estrella Immunopharma, Inc.'s Q2 2024 earnings report.

Estrella Immunopharma, Inc. (ESLA) reported Q2 2024 earnings on September 27, 2024 before market open.

Estrella Immunopharma, Inc. reported diluted EPS of $-0.13 for Q2 2024.

You can read the 10-K periodic report (0001213900-24-082374) directly on SEC EDGAR. The filing index links above go to sec.gov.